About FDA
Total number Clinical Pharmacology Advisory Committee meetings and OCP Co-sponsor meetings (i.e. Drug Information Association (DIA), Pharmaceutical Research and Manufacturers of America (PhRMA)) that OCP co-organizes and presents per quarter
Measure was implemented starting February 2010
Dictionary: These meetings with external parties are intended to resolve equivocal scientific issues that lead to clear policy for industry.
This measure has been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research.
Fiscal Year - 2010
Measure was implemented starting February 2010
| Time | Target | Number |
|---|---|---|
| Feb 2010 | N/A | 1 |
| Mar 2010 | N/A | 1 |
| Apr 2010 | N/A | 0 |
| May 2010 | N/A | 0 |
| Jun 2010 | N/A | 1 |
| Jul 2010 | N/A | 0 |
| Aug 2010 | N/A | 0 |
| Sep 2010 | N/A | 1 |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
